Equities

Airway Medix SA

Airway Medix SA

Actions
Health CareMedical Equipment and Services
  • Price (PLN)0.268
  • Today's Change-0.001 / -0.37%
  • Shares traded23.82k
  • 1 Year change-2.37%
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Airway Medix SA is a Poland-based company engaged in the biotechnology and medical research industry. The Company focuses on the research, development and commercialization of devices for single use in mechanically ventilated patients in intensive care units (ICU), and patients with life-threatening and anesthesiology division. It offers closed suction system, a closed cleaning system for simple hygiene treatment, endotracheal intubation tubes and oral care solution for cleaning the mouth.

  • Revenue in PLN (TTM)12.00k
  • Net income in PLN-3.28m
  • Incorporated2013
  • Employees1.00
  • Location
    Airway Medix SAul. Gen. Jozefa Zajaczka 11/14WARSZAWA 01-510PolandPOL
  • Phone+48 224084480
  • Fax+48 223009987
  • Websitehttp://www.airwaymedix.pl/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
VibroSense Dynamics AB759.99k-2.78m13.25m----3.61--17.43-0.5156-0.51560.13250.2920.18890.14419.78---69.18-46.24-85.81-53.0894.0285.61-366.26-551.223.09--0.00--22.8929.616.88---5.74--
Scandinavian ChemoTech AB1.03m-7.72m13.47m6.00--3.67--13.04-1.58-1.580.20940.6150.15430.32655.75470,333.30-115.35-87.29-168.57-118.5558.75252.05-747.38-2,122.770.8244-23.700.00--496.6219.137.28------
Scandinavian Real Heart AB0.00-26.22m14.16m11.00--0.5197-----0.7028-0.70280.000.76780.00----0.00-67.22-24.27-78.30-26.81--832.41---6,070.11---701.980.0945---100.00---385.97--1.91--
CM International SA31.44m136.53k15.28m53.00111.892.0116.180.48590.11350.113526.146.331.332.2810.93--0.57866.091.0110.1543.7647.280.43424.050.29050.7351-----8.5921.44-88.83-38.25-3.80--
SciBase Holding AB (publ)8.51m-20.34m16.53m27.00--0.8071--1.94-0.5854-0.58540.24180.35930.40720.75032.89860,962.90-97.36-68.63-143.11-87.7769.0061.28-239.12-300.202.56-32.77----29.9327.50-28.75--5.15--
Bioservo Technologies AB4.10m-17.11m18.18m28.00--1.29--4.44-0.111-0.1110.01750.03860.25420.66454.12---106.14-48.11-137.96-55.308.5845.22-417.51-366.442.53-4,273.180.00--35.8215.59-45.65---29.68--
Airway Medix SA12.00k-3.28m18.91m1.00------1,575.57-0.0548-0.05480.0002-0.21610.0018--0.018512,000.00-48.27-29.65---46.858.33---27,300.00-7,957.75---5.1711.35---87.37-58.0391.36------
iZafe Group AB1.83m-11.99m19.85m7.00--2.74--10.84-0.1614-0.16140.02160.07910.1091.242.46714,857.10-71.38-52.17-82.09-69.40-10.99---655.02-487.500.6947--0.1174--149.93-24.79-36.76---41.66--
Zortrax SA15.04m-14.74m20.50m93.00--0.1711--1.36-0.1277-0.12770.13031.040.10181.9417.62---9.98---11.16--47.94---98.03--0.8576-35.570.0412---62.55---68.52------
Kontigo Care AB10.59m76.84k22.02m10.00225.541.9614.762.080.00970.00971.201.120.7134--7.15--0.5175-0.42140.7527-0.619566.9666.310.7254-0.5205--2.370.1069--1.8016.95-92.68--44.94--
Inhalation Sciences Sweden AB6.40m-1.74m22.37m8.00--4.72--3.49-0.3575-0.35751.370.85411.120.94655.422,188,000.00-30.46-27.93-43.51-43.8279.7771.13-27.10-48.022.63-3.800.0776--43.5526.3360.87------
Nestmedic SA1.71m-6.48m22.72m9.00--14.96--13.30-0.2921-0.29210.07690.05520.12661.403.48189,826.70-48.00-56.34-79.88-112.88-201.84-239.95-379.30-497.001.53-20.140.4023---8.5070.26-30.83---60.10--
Surgical Innovations Group Plc59.82m-2.53m23.22m90.00--0.444918.810.3882-0.0005-0.00050.01290.01120.80322.855.89---3.40-8.19-4.18-9.9428.7032.51-4.24-13.311.23-4.450.1368--5.941.84-292.80--7.20--
Glycorex Transplantation AB (publ)10.96m-11.11m24.54m23.00--1.59--2.24-0.4111-0.41110.40570.59630.37010.3414--1,302,696.00-37.50-11.30-46.16-13.1789.6391.60-101.34-33.241.36-182.380.207---17.04-2.15-254.06---0.5593--
Myhealthchecked PLC74.41m941.00k25.89m15.0026.950.608315.710.3480.00370.00370.28850.16441.265.817.95996,400.001.59-20.092.21-28.2327.7922.621.26-13.423.53--0.0047--36.26190.36-24.30---12.80--
Data as of May 17 2024. Currency figures normalised to Airway Medix SA's reporting currency: Polish New Zloty PLN

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Investors TFI SAas of 31 Dec 20220.000.00%
Data from 30 Jun 2023 - 30 Jun 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.